BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 14, 2014
View Archived Issues
Discovery of a novel target in Plasmodium species leading to antimalarial drug development
Read More
HD Biosciences and Marshall University form cancer drug discovery agreement
Read More
Researchers present promising preclinical data for HM-12525A
Read More
Ipsen, Galderma/Nestle expand aesthetic dermatology businesses
Read More
Dignity Sciences reports data from phase II trial of DS-107E in atopic dermatitis
Read More
Ventana and Merck KGaA collaborate on companion diagnostic test
Read More
Plexxikon discloses new c-Kit inhibitors for cancer
Read More
Researchers at ChemoCentryx patent new CCR1 receptor antagonists
Read More
U.S. team discloses new 5-HT2C receptor agonists
Read More
Researchers report in vivo data for ZP-GA-1
Read More
Alios BioPharma divulges new NS5B inhibitors for HCV infection
Read More
Pfizer patents new EZH2 inhibitors for cancer
Read More
BioChaperone Lispro demonstrates a faster onset of action than naive insulin lispro
Read More
Bristol-Myers Squibb reports novel Abeta inhibitors
Read More
Hanmi presents promising results for HM-71224
Read More
ProStrakan to acquire Archimedes Pharma
Read More
Topline data reported from coBRIM study of cobimetinib in combination with vemurafenib
Read More
Brexpiprazole NDA submitted for schizophrenia and major depressive disorder
Read More
European orphan drug designations awarded to isavuconazole
Read More
Celgene set to study CC-220 in pilot phase II trial for SLE
Read More
Sialix changes name
Read More
Pfizer studies PF-06743649 in new phase I program for gout
Read More
New clinical data on remogliflozin etabonate presented
Read More
